BREITMEYER JAMES B
Insider CIK 1244823 · ONCT President, CEO, Director · CADX EVP, CMO · ZGNX Director · OTIC Director · VXRT Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VXRT Vaxart, Inc. | A Award deriv | 2026-07-16 | 2026-07-17 | 16,610 | — | $0 | 16,610 | SEC↗ |
| VXRT Vaxart, Inc. | A Award | 2026-07-16 | 2026-07-17 | 8,315 | — | $0 | 87,115 | SEC↗ |
| VXRT Vaxart, Inc. | A Award deriv | 2026-04-23 | 2026-05-01 | 157,400 | — | $0 | 157,400 | SEC↗ |
| VXRT Vaxart, Inc. | A Award | 2026-04-23 | 2026-05-01 | 78,800 | — | $0 | 78,800 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2024-02-14 | 2024-02-15 | 6,200 | — | $0 | 6,200 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2024-02-14 | 2024-02-15 | 28,400 | — | $0 | 28,400 | SEC↗ |
| ONCT Oncternal Therapeutics, In | F Tax w/h | 2024-01-03 | 2024-01-05 | 50,955 | $0.50 | $25.5K | 443,034 | SEC↗ |
| ONCT Oncternal Therapeutics, In | F Tax w/h | 2024-01-03 | 2024-01-05 | 4,485 | $0.50 | $2.2K | 15,426 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2023-10-02 | 2023-10-04 | 650,000 | — | $0 | 650,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2023-10-02 | 2023-10-04 | 123,750 | — | $0 | 123,750 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2023-10-02 | 2023-10-04 | 637,000 | — | $0 | 637,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2023-10-02 | 2023-10-04 | 750,000 | — | $0 | 750,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2023-10-02 | 2023-10-04 | 66,890 | — | $0 | 66,890 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2023-10-02 | 2023-10-04 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | D To issuer deriv | 2023-10-02 | 2023-10-04 | 650,000 | — | $0 | 0 | SEC↗ |
| ONCT Oncternal Therapeutics, In | D To issuer deriv | 2023-10-02 | 2023-10-04 | 123,750 | — | $0 | 0 | SEC↗ |
| ONCT Oncternal Therapeutics, In | D To issuer deriv | 2023-10-02 | 2023-10-04 | 637,000 | — | $0 | 0 | SEC↗ |
| ONCT Oncternal Therapeutics, In | D To issuer deriv | 2023-10-02 | 2023-10-04 | 750,000 | — | $0 | 0 | SEC↗ |
| ONCT Oncternal Therapeutics, In | D To issuer deriv | 2023-10-02 | 2023-10-04 | 66,890 | — | $0 | 0 | SEC↗ |
| ONCT Oncternal Therapeutics, In | D To issuer deriv | 2023-10-02 | 2023-10-04 | 100,000 | — | $0 | 0 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2023-10-02 | 2023-10-04 | 65,000 | — | $0 | 65,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2023-10-02 | 2023-10-04 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2023-10-02 | 2023-10-04 | 165,000 | — | $0 | 165,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2023-10-02 | 2023-10-04 | 2,000 | — | $0 | 2,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2023-10-02 | 2023-10-04 | 7,000 | — | $0 | 7,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2023-10-02 | 2023-10-04 | 22,000 | — | $0 | 12,240 | SEC↗ |
| ONCT Oncternal Therapeutics, In | D To issuer deriv | 2023-10-02 | 2023-10-04 | 65,000 | — | $0 | 0 | SEC↗ |
| ONCT Oncternal Therapeutics, In | D To issuer deriv | 2023-10-02 | 2023-10-04 | 12,500 | — | $0 | 0 | SEC↗ |
| ONCT Oncternal Therapeutics, In | D To issuer deriv | 2023-10-02 | 2023-10-04 | 165,000 | — | $0 | 0 | SEC↗ |
| ONCT Oncternal Therapeutics, In | D To issuer deriv | 2023-10-02 | 2023-10-04 | 2,000 | — | $0 | 0 | SEC↗ |
| ONCT Oncternal Therapeutics, In | D To issuer deriv | 2023-10-02 | 2023-10-04 | 7,000 | — | $0 | 0 | SEC↗ |
| ONCT Oncternal Therapeutics, In | D To issuer deriv | 2023-10-02 | 2023-10-04 | 22,000 | — | $0 | 0 | SEC↗ |
| ONCT Oncternal Therapeutics, In | F Tax w/h | 2023-07-03 | 2023-07-05 | 4,007 | $0.36 | $1.4K | 19,911 | SEC↗ |
| ONCT Oncternal Therapeutics, In | F Tax w/h | 2023-07-03 | 2023-07-05 | 47,992 | $0.36 | $17.3K | 493,989 | SEC↗ |
| ONCT Oncternal Therapeutics, In | P Buy | 2023-04-14 | 2023-04-17 | 47,750 | $0.30 | $14.3K | 194,294 | SEC↗ |
| ONCT Oncternal Therapeutics, In | P Buy | 2023-04-14 | 2023-04-17 | 2,250 | $0.29 | $653 | 196,544 | SEC↗ |
| ONCT Oncternal Therapeutics, In | P Buy | 2023-04-13 | 2023-04-17 | 100,000 | $0.29 | $29.0K | 146,544 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2023-02-21 | 2023-02-24 | 650,000 | — | $0 | 650,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2023-02-21 | 2023-02-24 | 65,000 | — | $0 | 65,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2023-02-21 | 2023-02-24 | 42,196 | — | $0 | 42,196 | SEC↗ |
| ONCT Oncternal Therapeutics, In | F Tax w/h | 2023-01-03 | 2023-01-05 | 27,793 | $1.02 | $28.3K | 541,981 | SEC↗ |
| ONCT Oncternal Therapeutics, In | F Tax w/h | 2023-01-03 | 2023-01-05 | 1,325 | $1.02 | $1.4K | 23,918 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2022-07-28 | 2022-08-01 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2022-07-28 | 2022-08-01 | 123,750 | — | $0 | 123,750 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award | 2022-07-28 | 2022-08-01 | 185,625 | — | $0 | 569,774 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award | 2022-07-28 | 2022-08-01 | 18,750 | — | $0 | 25,243 | SEC↗ |
| OTIC OTONOMY, INC. | A Award deriv | 2022-06-21 | 2022-06-23 | 27,500 | — | $0 | 27,500 | SEC↗ |
| ZGNX ZOGENIX, INC. | D To issuer deriv | 2022-03-07 | 2022-03-09 | 9,000 | — | $0 | 0 | SEC↗ |
| ZGNX ZOGENIX, INC. | D To issuer deriv | 2022-03-07 | 2022-03-09 | 20,000 | — | $0 | 0 | SEC↗ |
| ZGNX ZOGENIX, INC. | D To issuer deriv | 2022-03-07 | 2022-03-09 | 10,000 | — | $0 | 0 | SEC↗ |
| ZGNX ZOGENIX, INC. | D To issuer deriv | 2022-03-07 | 2022-03-09 | 22,000 | — | $0 | 0 | SEC↗ |
| ZGNX ZOGENIX, INC. | D To issuer deriv | 2022-03-07 | 2022-03-09 | 6,250 | — | $0 | 0 | SEC↗ |
| ZGNX ZOGENIX, INC. | D To issuer deriv | 2022-03-07 | 2022-03-09 | 9,375 | — | $0 | 0 | SEC↗ |
| ZGNX ZOGENIX, INC. | U Tender | 2022-03-07 | 2022-03-09 | 1,250 | — | $0 | 0 | SEC↗ |
| ONCT Oncternal Therapeutics, In | P Buy | 2022-01-27 | 2022-01-31 | 25,000 | $1.68 | $42.0K | 46,544 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2022-01-20 | 2022-01-24 | 165,000 | — | $0 | 165,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2022-01-20 | 2022-01-24 | 637,000 | — | $0 | 637,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award | 2022-01-03 | 2022-01-05 | 6,793 | — | $0 | 6,793 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award | 2022-01-03 | 2022-01-05 | 128,557 | — | $0 | 384,149 | SEC↗ |
| OTIC OTONOMY, INC. | A Award deriv | 2021-06-22 | 2021-06-24 | 17,500 | — | $0 | 17,500 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2021-05-27 | 2021-05-28 | 22,000 | — | $0 | 22,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2021-03-18 | 2021-03-22 | 63,295 | — | $0 | 105,492 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2021-02-21 | 2021-02-23 | 2,000 | — | $0 | 2,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2021-02-11 | 2021-02-16 | 750,000 | — | $0 | 750,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2021-01-27 | 2021-02-23 | 7,000 | — | $0 | 7,000 | SEC↗ |
| OTIC OTONOMY, INC. | A Award deriv | 2020-06-23 | 2020-06-25 | 17,500 | — | $0 | 17,500 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2020-05-29 | 2020-06-29 | 13,000 | — | $0 | 13,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2020-03-17 | 2020-07-31 | 66,890 | — | $0 | 66,890 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2020-03-17 | 2020-03-18 | 66,890 | — | $0 | 66,890 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2020-01-07 | 2020-07-31 | 22,000 | — | $0 | 22,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2020-01-07 | 2020-01-09 | 22,000 | — | $0 | 22,000 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise deriv | 2019-12-16 | 2019-12-18 | 5,000 | — | $0 | 10,000 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise | 2019-12-16 | 2019-12-18 | 5,000 | $8.99 | $45.0K | 6,250 | SEC↗ |
| ZGNX ZOGENIX, INC. | S Sale | 2019-12-16 | 2019-12-18 | 5,000 | $50.00 | $250.0K | 1,250 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise deriv | 2019-11-25 | 2019-11-27 | 5,000 | — | $0 | 15,000 | SEC↗ |
| ZGNX ZOGENIX, INC. | S Sale | 2019-11-25 | 2019-11-27 | 5,000 | $50.00 | $250.0K | 1,250 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise | 2019-11-25 | 2019-11-27 | 5,000 | $8.99 | $45.0K | 6,250 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2019-09-12 | 2020-07-31 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2019-09-12 | 2019-09-16 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2019-06-18 | 2019-06-20 | 42,196 | — | $0 | 42,196 | SEC↗ |
| OTIC OTONOMY, INC. | A Award deriv | 2019-06-11 | 2019-06-13 | 17,500 | — | $0 | 17,500 | SEC↗ |
| ONCT GTX INC /DE/ | A Award deriv | 2019-06-07 | 2019-06-11 | 733 | — | $0 | 733 | SEC↗ |
| ONCT GTX INC /DE/ | A Award deriv | 2019-06-07 | 2019-06-11 | 117,417 | — | $0 | 117,417 | SEC↗ |
| ONCT GTX INC /DE/ | A Award deriv | 2019-06-07 | 2019-06-11 | 1,467 | — | $0 | 1,467 | SEC↗ |
| ONCT GTX INC /DE/ | A Award | 2019-06-07 | 2019-06-11 | 21,544 | — | $0 | 21,544 | SEC↗ |
| ONCT GTX INC /DE/ | A Award | 2019-06-07 | 2019-06-11 | 255,591 | — | $0 | 255,591 | SEC↗ |
| ONCT GTX INC /DE/ | A Award | 2019-06-07 | 2019-06-11 | 733 | — | $0 | 733 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2019-05-22 | 2019-05-28 | 13,000 | — | $0 | 13,000 | SEC↗ |
| OTIC OTONOMY, INC. | A Award deriv | 2018-06-19 | 2018-06-20 | 35,000 | — | $0 | 35,000 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2018-05-23 | 2018-05-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2017-05-23 | 2017-05-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2016-07-13 | 2016-07-15 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2015-06-18 | 2015-06-19 | 72,000 | — | $0 | 72,000 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2014-05-21 | 2014-05-22 | 50,000 | — | $0 | 125,000 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2014-05-21 | 2014-05-22 | 50,000 | — | $0 | 125,000 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2014-03-25 | 2014-03-26 | 75,000 | — | $0 | 75,000 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | A Award deriv | 2012-03-14 | 2012-03-16 | 36,577 | — | $0 | 36,577 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | A Award deriv | 2012-03-14 | 2012-03-16 | 150,000 | — | $0 | 150,000 | SEC↗ |